Mindfulness Training for Pregnancy-Related Hypertension
Trial Summary
What is the purpose of this trial?
Hypertensive disorders of pregnancy (HDP) are the most common medical condition affecting pregnancy and a leading cause of maternal morbidity and mortality in the Unites States. HDP also increase lifetime cardiac disease risk in women and infants. Current interventions to prevent HDP are limited, and interventions that do not include medications are minimally effective at preventing HDP. Mindfulness interventions hold promise as a intervention to prevent HDP that does not require pregnant women to take medications. Past research shows that mindfulness interventions reduce blood pressure in adults with hypertension and pre-hypertension. However, past studies of mindfulness interventions for pregnant women have not allowed women at risk for HDP to participate. The preliminary study of prenatal mindfulness training for women at risk for HDP demonstrated benefit on maternal blood pressure and fetal growth. However, the mechanisms explaining effects of prenatal mindfulness training on risk for HDP are unknown. Building upon these promising preliminary findings, the proposed clinical trial will measure daily experiences of stress, physiological reactivity to stress, and interpersonal processes before and after prenatal mindfulness training. The investigators hypothesize that mindfulness training will impact these processes, which may lead to improved maternal cardiovascular parameters and reduced risk for HDP. N=150 pregnant women at risk for HDP will be randomized to an 8-week phone-delivered mindfulness intervention or usual care. For every participant, we will measure maternal cardiovascular parameters (24-hour blood pressure and uterine artery resistance values by ultrasound Doppler) before and after the 8-week period. All participants will complete surveys of daily experiences for 2 weeks before and after the 8-week period to evaluate mechanisms of mindfulness training on maternal cardiovascular parameters. Daily experiences will be measured using surveys delivered via smartphone-app, ambient audio sampling, and wearable wrist-worn biosensor monitoring (heart rate and heart rate variability).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on mindfulness training as an additional intervention, so it's best to discuss your medications with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Mindfulness training for pregnancy-related hypertension?
Research shows that mindfulness training can help reduce stress, anxiety, and depression in pregnant women, which are factors that can contribute to high blood pressure. While the studies focus on mental health benefits, these improvements may indirectly support better blood pressure management during pregnancy.12345
Is mindfulness training safe for pregnant women?
How does mindfulness training differ from other treatments for pregnancy-related hypertension?
Mindfulness training is unique because it focuses on reducing stress and improving mental well-being through meditation and awareness practices, which can indirectly help manage high blood pressure during pregnancy. Unlike medications, it does not involve taking drugs and instead aims to lower stress hormones like cortisol, which may contribute to hypertension.147910
Research Team
Margaret H Bublitz
Principal Investigator
The Miriam Hospital
Eligibility Criteria
This trial is for English-speaking pregnant women under 20 weeks' gestation, with blood pressure below 140/90, and at moderate to high risk for hypertensive disorders. It's not for those with multiple pregnancies, severe depression or psychosis, or who regularly practice mind-body activities like yoga or meditation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Measurement of maternal cardiovascular parameters and completion of surveys of daily experiences
Treatment
Participants receive an 8-week phone-delivered mindfulness intervention or usual care
Post-Treatment Assessment
Re-assessment of maternal cardiovascular parameters and completion of surveys of daily experiences
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Mindfulness training
Mindfulness training is already approved in European Union, United States for the following indications:
- Stress reduction
- Anxiety management
- Depression management
- Stress reduction
- Anxiety management
- Depression management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lifespan
Lead Sponsor